<DOC>
	<DOCNO>NCT00361881</DOCNO>
	<brief_summary>The purpose study determine whether ME-609 efficient acyclovir placebo treatment recurrent herpes labialis .</brief_summary>
	<brief_title>Efficacy Safety Study ME-609 Acyclovir Treatment Herpes Simplex Labialis</brief_title>
	<detailed_description>This randomize , double-blind , active- vehicle-controlled study compare effect ME-609 , acyclovir ME-609 vehicle , vehicle alone . Treatment subject-initiated within 1 hour experience first sign symptom herpes recurrence . The subject visit study clinic soon possible treatment initiation , later midnight follow day , evaluation .</detailed_description>
	<mesh_term>Herpes Simplex</mesh_term>
	<mesh_term>Herpes Labialis</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Generally good health History recurrent herpes labialis last three episode prior 12 month Treatment antiviral immunosuppressive agent within 2 week prior randomization Pregnant and/or nurse woman Continuous daily treatment pain medication Significant skin condition occur area herpes recurrence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>